Caution, this is an AI generated summary based on literature. This may have errors, see here for more.
Please share your feedback with us.
MIR223: MIR223 is a microRNA that has been found to play a role in various biological processes. In MIR223 deficient mice, an increase in granulocyte numbers and abnormal phenotype has been observed, leading to the development of inflammatory lung pathology [PMC7871001]. Microarray analyses have shown that MIR223 is enriched in microglia [PMC6351131]. Another short RNA, MIR223 derived from thrombin activated PL-EVs, has been found to regulate the endothelial expression of FBXW7 and EFNA1 mRNA targets [PMC8468534]. While upregulation of MIR223 in peripheral plasma has been reported, its expression was significantly decreased in SLE patients with active nephritis [PMC7871001]. CircMTO1 was found to act as a sponge for both miR9 and MIR223 [PMC7093694]. In hepatocellular carcinoma (HCC), MIR223 levels are depleted in tissues but its concentration rises in serum, suggesting its potential as a serum biomarker for HCC [PMC4581219]. Mutated rs3750996 was reported to affect the binding affinity of MIR223 but further investigations are needed to determine its influence on STIM1 gene expression [PMC7767290]. Deregulated miRNAs such as miR199-214, miR371-373, and MIR223 have been implicated in various cellular processes including tumor metabolism, p53 pathway regulation, cell cycle regulation, Wnt/β-catenin signaling, apoptosis and cell growth through FBXW7 [PMC9495386]. In the miRNA-mediated synaptic plasticity regulating pathway, MIR501 targets GluR1 while both MIR223 and miR134 target GluR2 and NR2B respectively [PMC4783348].
Genome locations
Gene Ontology annotations
Ancestor Chart
Loading ontology ancestors...
Failed to load QuickGO Ancestor chart
Sequence
Sequence features are shown above as colored rectangles.
Zoom in and click to view details, or
Reset